APO Research
Talk to an analyst

APO RESEARCH · REPORT

RSV Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global RSV Vaccine Market Analysis and Forecast 2026-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchRSV Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal RSV Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal RSV Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RSV Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal RSV Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global RSV Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for RSV Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for RSV Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for RSV Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for RSV Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of RSV Vaccine include Nuance Pharma, Pfizer, GSK, Advaccine, Moderna, JNJ and Bavarian Nordic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for RSV Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of RSV Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for RSV Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the RSV Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global RSV Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for RSV Vaccine sales, projected growth trends, production technology, application and end-user industry.

RSV Vaccine Segment by Company

Nuance Pharma

Pfizer

GSK

Advaccine

Moderna

JNJ

Bavarian Nordic

RSV Vaccine Segment by Type

Being Developed

Preclinical

Clinical III

Clinical II

Clinical I

RSV Vaccine Segment by Application

Elderly Vaccine

Infant Vaccine

Others

RSV Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RSV Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RSV Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RSV Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of RSV Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RSV Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RSV Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Being Developed Major Manufacturers Table 3. Preclinical Major Manufacturers Table 4. Clinical III Major Manufacturers Table 5. Clinical II Major Manufacturers Table 6. Clinical I Major Manufacturers Table 7. Global RSV Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Elderly Vaccine Major Manufacturers Table 9. Infant Vaccine Major Manufacturers Table 10. Others Major Manufacturers Table 11. RSV Vaccine Industry Trends Table 12. RSV Vaccine Industry Drivers Table 13. RSV Vaccine Industry Opportunities and Challenges Table 14. RSV Vaccine Industry Restraints Table 15. Global RSV Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global RSV Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 17. Global RSV Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 18. Global RSV Vaccine Revenue Market Share by Region (2021-2026) Table 19. Global RSV Vaccine Revenue Market Share by Region (2027-2032) Table 20. Global RSV Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global RSV Vaccine Sales by Region (2021-2026) & (k units) Table 22. Global RSV Vaccine Sales by Region (2027-2032) & (k units) Table 23. Global RSV Vaccine Sales Market Share by Region (2021-2026) Table 24. Global RSV Vaccine Sales Market Share by Region (2027-2032) Table 25. Global RSV Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global RSV Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 27. Global RSV Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global RSV Vaccine Sales Market Share by Manufacturers (2021-2026) Table 29. Global RSV Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global RSV Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global RSV Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global RSV Vaccine Manufacturers, Product Type & Application Table 33. Global RSV Vaccine Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global RSV Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global RSV Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 38. Global RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 39. Global RSV Vaccine Revenue Market Share by Type (2021-2026) Table 40. Global RSV Vaccine Revenue Market Share by Type (2027-2032) Table 41. Global RSV Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global RSV Vaccine Sales by Type (2021-2026) & (k units) Table 43. Global RSV Vaccine Sales by Type (2027-2032) & (k units) Table 44. Global RSV Vaccine Sales Market Share by Type (2021-2026) Table 45. Global RSV Vaccine Sales Market Share by Type (2027-2032) Table 46. Global RSV Vaccine Price by Type (2021-2026) & (US$/unit) Table 47. Global RSV Vaccine Price by Type (2027-2032) & (US$/unit) Table 48. Global RSV Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 50. Global RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 51. Global RSV Vaccine Revenue Market Share by Application (2021-2026) Table 52. Global RSV Vaccine Revenue Market Share by Application (2027-2032) Table 53. Global RSV Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global RSV Vaccine Sales by Application (2021-2026) & (k units) Table 55. Global RSV Vaccine Sales by Application (2027-2032) & (k units) Table 56. Global RSV Vaccine Sales Market Share by Application (2021-2026) Table 57. Global RSV Vaccine Sales Market Share by Application (2027-2032) Table 58. Global RSV Vaccine Price by Application (2021-2026) & (US$/unit) Table 59. Global RSV Vaccine Price by Application (2027-2032) & (US$/unit) Table 60. Nuance Pharma Company Information Table 61. Nuance Pharma Business Overview Table 62. Nuance Pharma RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Nuance Pharma RSV Vaccine Product Portfolio Table 64. Nuance Pharma Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Pfizer RSV Vaccine Product Portfolio Table 69. Pfizer Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. GSK RSV Vaccine Product Portfolio Table 74. GSK Recent Development Table 75. Advaccine Company Information Table 76. Advaccine Business Overview Table 77. Advaccine RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Advaccine RSV Vaccine Product Portfolio Table 79. Advaccine Recent Development Table 80. Moderna Company Information Table 81. Moderna Business Overview Table 82. Moderna RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Moderna RSV Vaccine Product Portfolio Table 84. Moderna Recent Development Table 85. JNJ Company Information Table 86. JNJ Business Overview Table 87. JNJ RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. JNJ RSV Vaccine Product Portfolio Table 89. JNJ Recent Development Table 90. Bavarian Nordic Company Information Table 91. Bavarian Nordic Business Overview Table 92. Bavarian Nordic RSV Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Bavarian Nordic RSV Vaccine Product Portfolio Table 94. Bavarian Nordic Recent Development Table 95. North America RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 96. North America RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 97. North America RSV Vaccine Sales by Type (2021-2026) & (k units) Table 98. North America RSV Vaccine Sales by Type (2027-2032) & (k units) Table 99. North America RSV Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 100. North America RSV Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 101. North America RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 102. North America RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 103. North America RSV Vaccine Sales by Application (2021-2026) & (k units) Table 104. North America RSV Vaccine Sales by Application (2027-2032) & (k units) Table 105. North America RSV Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 106. North America RSV Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 107. North America RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America RSV Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America RSV Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America RSV Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 111. North America RSV Vaccine Sales by Country (2021-2026) & (k units) Table 112. North America RSV Vaccine Sales by Country (2027-2032) & (k units) Table 113. North America RSV Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 114. North America RSV Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 115. United States RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 116. Canada RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Mexico RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Europe RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe RSV Vaccine Sales by Type (2021-2026) & (k units) Table 121. Europe RSV Vaccine Sales by Type (2027-2032) & (k units) Table 122. Europe RSV Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 123. Europe RSV Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 124. Europe RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe RSV Vaccine Sales by Application (2021-2026) & (k units) Table 127. Europe RSV Vaccine Sales by Application (2027-2032) & (k units) Table 128. Europe RSV Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 129. Europe RSV Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 130. Europe RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe RSV Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. Europe RSV Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. Europe RSV Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 134. Europe RSV Vaccine Sales by Country (2021-2026) & (k units) Table 135. Europe RSV Vaccine Sales by Country (2027-2032) & (k units) Table 136. Europe RSV Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 137. Europe RSV Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 138. Germany RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 139. France RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 140. U.K. RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 141. Italy RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Russia RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Spain RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Netherlands RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Switzerland RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Sweden RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Poland RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 148. China RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 149. China RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 150. China RSV Vaccine Sales by Type (2021-2026) & (k units) Table 151. China RSV Vaccine Sales by Type (2027-2032) & (k units) Table 152. China RSV Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 153. China RSV Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 154. China RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 155. China RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 156. China RSV Vaccine Sales by Application (2021-2026) & (k units) Table 157. China RSV Vaccine Sales by Application (2027-2032) & (k units) Table 158. China RSV Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 159. China RSV Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 160. Asia RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia RSV Vaccine Sales by Type (2021-2026) & (k units) Table 163. Asia RSV Vaccine Sales by Type (2027-2032) & (k units) Table 164. Asia RSV Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 165. Asia RSV Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 166. Asia RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia RSV Vaccine Sales by Application (2021-2026) & (k units) Table 169. Asia RSV Vaccine Sales by Application (2027-2032) & (k units) Table 170. Asia RSV Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 171. Asia RSV Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 172. Asia RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia RSV Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia RSV Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia RSV Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 176. Asia RSV Vaccine Sales by Country (2021-2026) & (k units) Table 177. Asia RSV Vaccine Sales by Country (2027-2032) & (k units) Table 178. Asia RSV Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 179. Asia RSV Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 180. Japan RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 181. South Korea RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 182. India RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Australia RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Taiwan RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 186. SAMEA RSV Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA RSV Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA RSV Vaccine Sales by Type (2021-2026) & (k units) Table 189. SAMEA RSV Vaccine Sales by Type (2027-2032) & (k units) Table 190. SAMEA RSV Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 191. SAMEA RSV Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 192. SAMEA RSV Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA RSV Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA RSV Vaccine Sales by Application (2021-2026) & (k units) Table 195. SAMEA RSV Vaccine Sales by Application (2027-2032) & (k units) Table 196. SAMEA RSV Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 197. SAMEA RSV Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 198. SAMEA RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA RSV Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA RSV Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA RSV Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 202. SAMEA RSV Vaccine Sales by Country (2021-2026) & (k units) Table 203. SAMEA RSV Vaccine Sales by Country (2027-2032) & (k units) Table 204. SAMEA RSV Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 205. SAMEA RSV Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 206. Brazil RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Argentina RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Chile RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Colombia RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Peru RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Israel RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 213. UAE RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Turkey RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Iran RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Egypt RSV Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. RSV Vaccine Distributors List Table 220. RSV Vaccine Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. RSV Vaccine Image Figure 2. Global RSV Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RSV Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Being Developed Image Figure 5. Preclinical Image Figure 6. Clinical III Image Figure 7. Clinical II Image Figure 8. Clinical I Image Figure 9. Global RSV Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global RSV Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 11. Elderly Vaccine Image Figure 12. Infant Vaccine Image Figure 13. Others Image Figure 14. Global RSV Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global RSV Vaccine Revenue (2021-2032) & (US$ Million) Figure 16. Global RSV Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global RSV Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global RSV Vaccine Revenue Market Share by Region (2021-2032) Figure 19. Global RSV Vaccine Sales (2021-2032) & (k units) Figure 20. Global RSV Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global RSV Vaccine Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico RSV Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Europe RSV Vaccine Sales YoY (2021-2032) & (k units) Figure 24. China RSV Vaccine Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) RSV Vaccine Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa RSV Vaccine Sales YoY (2021-2032) & (k units) Figure 27. Global RSV Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global RSV Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global RSV Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global RSV Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global RSV Vaccine Revenue Market Share by Type (2021-2032) Figure 33. Global RSV Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global RSV Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global RSV Vaccine Sales Market Share by Type (2021-2032) Figure 36. Global RSV Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global RSV Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global RSV Vaccine Revenue Market Share by Application (2021-2032) Figure 39. Global RSV Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global RSV Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global RSV Vaccine Sales Market Share by Application (2021-2032) Figure 42. North America RSV Vaccine Revenue Share by Type (2021-2032) Figure 43. North America RSV Vaccine Sales Share by Type (2021-2032) Figure 44. North America RSV Vaccine Revenue Share by Application (2021-2032) Figure 45. North America RSV Vaccine Sales Share by Application (2021-2032) Figure 46. North America RSV Vaccine Revenue Share by Country (2021-2032) Figure 47. North America RSV Vaccine Sales Share by Country (2021-2032) Figure 48. Europe RSV Vaccine Revenue Share by Type (2021-2032) Figure 49. Europe RSV Vaccine Sales Share by Type (2021-2032) Figure 50. Europe RSV Vaccine Revenue Share by Application (2021-2032) Figure 51. Europe RSV Vaccine Sales Share by Application (2021-2032) Figure 52. Europe RSV Vaccine Revenue Share by Country (2021-2032) Figure 53. Europe RSV Vaccine Sales Share by Country (2021-2032) Figure 54. China RSV Vaccine Revenue Share by Type (2021-2032) Figure 55. China RSV Vaccine Sales Share by Type (2021-2032) Figure 56. China RSV Vaccine Revenue Share by Application (2021-2032) Figure 57. China RSV Vaccine Sales Share by Application (2021-2032) Figure 58. Asia RSV Vaccine Revenue Share by Type (2021-2032) Figure 59. Asia RSV Vaccine Sales Share by Type (2021-2032) Figure 60. Asia RSV Vaccine Revenue Share by Application (2021-2032) Figure 61. Asia RSV Vaccine Sales Share by Application (2021-2032) Figure 62. Asia RSV Vaccine Revenue Share by Country (2021-2032) Figure 63. Asia RSV Vaccine Sales Share by Country (2021-2032) Figure 64. SAMEA RSV Vaccine Revenue Share by Type (2021-2032) Figure 65. SAMEA RSV Vaccine Sales Share by Type (2021-2032) Figure 66. SAMEA RSV Vaccine Revenue Share by Application (2021-2032) Figure 67. SAMEA RSV Vaccine Sales Share by Application (2021-2032) Figure 68. SAMEA RSV Vaccine Revenue Share by Country (2021-2032) Figure 69. SAMEA RSV Vaccine Sales Share by Country (2021-2032) Figure 70. RSV Vaccine Value Chain Figure 71. Manufacturing Cost Structure Figure 72. RSV Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Being Developed
  • Preclinical
  • Clinical III
  • Clinical II
  • Clinical I
Applications
  • Elderly Vaccine
  • Infant Vaccine
  • Others
Companies covered
  • Nuance Pharma
  • Pfizer
  • GSK
  • Advaccine
  • Moderna
  • JNJ
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 RSV Vaccine Market by Type
  3. 1.2.1 Global RSV Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Being Developed
  5. 1.2.3 Preclinical
  6. 1.2.4 Clinical III
  7. 1.2.5 Clinical II
  8. 1.2.6 Clinical I
  9. 1.3 RSV Vaccine Market by Application
  10. 1.3.1 Global RSV Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Elderly Vaccine
  12. 1.3.3 Infant Vaccine
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 RSV Vaccine Market Dynamics
  1. 2.1 RSV Vaccine Industry Trends
  2. 2.2 RSV Vaccine Industry Drivers
  3. 2.3 RSV Vaccine Industry Opportunities and Challenges
  4. 2.4 RSV Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global RSV Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global RSV Vaccine Revenue by Region
  3. 3.2.1 Global RSV Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global RSV Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global RSV Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global RSV Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global RSV Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global RSV Vaccine Sales by Region
  9. 3.4.1 Global RSV Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global RSV Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global RSV Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global RSV Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global RSV Vaccine Revenue by Manufacturers
  2. 4.1.1 Global RSV Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global RSV Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global RSV Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global RSV Vaccine Sales by Manufacturers
  6. 4.2.1 Global RSV Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global RSV Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global RSV Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global RSV Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global RSV Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global RSV Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global RSV Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global RSV Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global RSV Vaccine Market CR5 and HHI
  16. 4.8.2 2025 RSV Vaccine Tier 1, Tier 2, and Tier 3
5 RSV Vaccine Market by Type
  1. 5.1 Global RSV Vaccine Revenue by Type
  2. 5.1.1 Global RSV Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global RSV Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global RSV Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global RSV Vaccine Sales by Type
  6. 5.2.1 Global RSV Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global RSV Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global RSV Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global RSV Vaccine Price by Type
6 RSV Vaccine Market by Application
  1. 6.1 Global RSV Vaccine Revenue by Application
  2. 6.1.1 Global RSV Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global RSV Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global RSV Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global RSV Vaccine Sales by Application
  6. 6.2.1 Global RSV Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global RSV Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global RSV Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global RSV Vaccine Price by Application
7 Company Profiles
  1. 7.1 Nuance Pharma
  2. 7.1.1 Nuance Pharma Company Information
  3. 7.1.2 Nuance Pharma Business Overview
  4. 7.1.3 Nuance Pharma RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Nuance Pharma RSV Vaccine Product Portfolio
  6. 7.1.5 Nuance Pharma Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer RSV Vaccine Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK RSV Vaccine Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Advaccine
  20. 7.4.1 Advaccine Company Information
  21. 7.4.2 Advaccine Business Overview
  22. 7.4.3 Advaccine RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Advaccine RSV Vaccine Product Portfolio
  24. 7.4.5 Advaccine Recent Developments
  25. 7.5 Moderna
  26. 7.5.1 Moderna Company Information
  27. 7.5.2 Moderna Business Overview
  28. 7.5.3 Moderna RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Moderna RSV Vaccine Product Portfolio
  30. 7.5.5 Moderna Recent Developments
  31. 7.6 JNJ
  32. 7.6.1 JNJ Company Information
  33. 7.6.2 JNJ Business Overview
  34. 7.6.3 JNJ RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 JNJ RSV Vaccine Product Portfolio
  36. 7.6.5 JNJ Recent Developments
  37. 7.7 Bavarian Nordic
  38. 7.7.1 Bavarian Nordic Company Information
  39. 7.7.2 Bavarian Nordic Business Overview
  40. 7.7.3 Bavarian Nordic RSV Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bavarian Nordic RSV Vaccine Product Portfolio
  42. 7.7.5 Bavarian Nordic Recent Developments
8 North America
  1. 8.1 North America RSV Vaccine Market Size by Type
  2. 8.1.1 North America RSV Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America RSV Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America RSV Vaccine Price by Type (2021-2032)
  5. 8.2 North America RSV Vaccine Market Size by Application
  6. 8.2.1 North America RSV Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America RSV Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America RSV Vaccine Price by Application (2021-2032)
  9. 8.3 North America RSV Vaccine Market Size by Country
  10. 8.3.1 North America RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America RSV Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America RSV Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe RSV Vaccine Market Size by Type
  2. 9.1.1 Europe RSV Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe RSV Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe RSV Vaccine Price by Type (2021-2032)
  5. 9.2 Europe RSV Vaccine Market Size by Application
  6. 9.2.1 Europe RSV Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe RSV Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe RSV Vaccine Price by Application (2021-2032)
  9. 9.3 Europe RSV Vaccine Market Size by Country
  10. 9.3.1 Europe RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe RSV Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe RSV Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China RSV Vaccine Market Size by Type
  2. 10.1.1 China RSV Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China RSV Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China RSV Vaccine Price by Type (2021-2032)
  5. 10.2 China RSV Vaccine Market Size by Application
  6. 10.2.1 China RSV Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China RSV Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China RSV Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia RSV Vaccine Market Size by Type
  2. 11.1.1 Asia RSV Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia RSV Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia RSV Vaccine Price by Type (2021-2032)
  5. 11.2 Asia RSV Vaccine Market Size by Application
  6. 11.2.1 Asia RSV Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia RSV Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia RSV Vaccine Price by Application (2021-2032)
  9. 11.3 Asia RSV Vaccine Market Size by Country
  10. 11.3.1 Asia RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia RSV Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia RSV Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA RSV Vaccine Market Size by Type
  2. 12.1.1 SAMEA RSV Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA RSV Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA RSV Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA RSV Vaccine Market Size by Application
  6. 12.2.1 SAMEA RSV Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA RSV Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA RSV Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA RSV Vaccine Market Size by Country
  10. 12.3.1 SAMEA RSV Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA RSV Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA RSV Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 RSV Vaccine Value Chain Analysis
  2. 13.1.1 RSV Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 RSV Vaccine Production Mode & Process
  6. 13.2 RSV Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 RSV Vaccine Distributors
  9. 13.2.3 RSV Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst